YPF Sociedad Anonima (YPF) Reaches $20.07 Formed H&S; Shorts at Biolife Solutions (BLFS) Raised By 1.78%

BioLife Solutions, Inc. (NASDAQ:BLFS) Logo

Biolife Solutions Inc (NASDAQ:BLFS) had an increase of 1.78% in short interest. BLFS’s SI was 673,100 shares in May as released by FINRA. Its up 1.78% from 661,300 shares previously. With 40,800 avg volume, 17 days are for Biolife Solutions Inc (NASDAQ:BLFS)’s short sellers to cover BLFS’s short positions. The SI to Biolife Solutions Inc’s float is 9.97%. The stock increased 4.62% or $0.4 during the last trading session, reaching $9.06. About 122,500 shares traded or 14.37% up from the average. BioLife Solutions, Inc. (NASDAQ:BLFS) has risen 143.54% since May 18, 2017 and is uptrending. It has outperformed by 131.99% the S&P500.

YPF Sociedad Anonima (YPF) formed H&S with $18.46 target or 8.00% below today’s $20.07 share price. YPF Sociedad Anonima (YPF) has $8.65 billion valuation. The stock increased 0.96% or $0.19 during the last trading session, reaching $20.07. About 1.19M shares traded or 13.40% up from the average. YPF Sociedad Anonima (NYSE:YPF) has declined 8.58% since May 18, 2017 and is downtrending. It has underperformed by 20.13% the S&P500.

Investors sentiment decreased to 2.83 in Q4 2017. Its down 5.17, from 8 in 2017Q3. It is negative, as 2 investors sold BioLife Solutions, Inc. shares while 4 reduced holdings. 8 funds opened positions while 9 raised stakes. 1.37 million shares or 30.77% less from 1.98 million shares in 2017Q3 were reported. Geode Mngmt Ltd Liability Com holds 0% of its portfolio in BioLife Solutions, Inc. (NASDAQ:BLFS) for 69,384 shares. Wells Fargo & Mn stated it has 0% in BioLife Solutions, Inc. (NASDAQ:BLFS). Northern Tru reported 0% stake. Morgan Stanley has 0% invested in BioLife Solutions, Inc. (NASDAQ:BLFS). Millennium Mgmt Ltd Liability has invested 0% in BioLife Solutions, Inc. (NASDAQ:BLFS). Blackrock holds 0% or 37,232 shares. C M Bidwell Associates Limited holds 5,030 shares. Hudock Capital Ltd Liability Co holds 0% of its portfolio in BioLife Solutions, Inc. (NASDAQ:BLFS) for 43 shares. Salem Counselors Inc reported 72 shares. Price T Rowe Associate Md owns 24,800 shares for 0% of their portfolio. 5,600 were reported by Macquarie Group Incorporated Limited. Granite Invest Prtnrs Ltd Liability holds 0.08% or 211,030 shares. Deutsche Bancorporation Ag holds 0% or 37,600 shares in its portfolio. Thompson Davis & Inc owns 4,000 shares for 0.06% of their portfolio. Royal Retail Bank Of Canada invested 0% of its portfolio in BioLife Solutions, Inc. (NASDAQ:BLFS).

Since January 16, 2018, it had 0 insider purchases, and 6 sales for $5.79 million activity. Shares for $65,960 were sold by Rice Michael on Thursday, February 15. GIRSCHWEILER THOMAS had sold 1.03M shares worth $5.39 million.

Among 3 analysts covering BioLife Solutions (NASDAQ:BLFS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLife Solutions had 8 analyst reports since June 14, 2017 according to SRatingsIntel. Maxim Group maintained it with “Buy” rating and $500 target in Monday, July 31 report. Maxim Group maintained BioLife Solutions, Inc. (NASDAQ:BLFS) on Friday, August 11 with “Buy” rating. The stock of BioLife Solutions, Inc. (NASDAQ:BLFS) has “Buy” rating given on Wednesday, July 5 by Janney Capital. Maxim Group upgraded the stock to “Buy” rating in Thursday, November 30 report. The rating was maintained by Maxim Group on Friday, November 10 with “Buy”. Northland Capital initiated it with “Buy” rating and $7.5 target in Monday, March 12 report. Maxim Group maintained the stock with “Buy” rating in Wednesday, June 14 report. The rating was maintained by Maxim Group on Friday, May 11 with “Buy”.

BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company has market cap of $136.85 million. The Company’s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. It currently has negative earnings. The firm offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing.

More notable recent BioLife Solutions, Inc. (NASDAQ:BLFS) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings” on May 16, 2018, also Nasdaq.com with their article: “Detailed Research: Economic Perspectives on Natural Health Trends, BioLife Solutions, The Chefs’ Warehouse …” published on April 26, 2018, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer’s Trial …” on May 10, 2018. More interesting news about BioLife Solutions, Inc. (NASDAQ:BLFS) were released by: Gurufocus.com and their article: “BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative …” published on May 16, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy’s Revenue Miss, FDA Warns E-Liquid Makers Again” with publication date: May 11, 2018.

YPF Sociedad Anonima (NYSE:YPF) Institutional Positions Chart